Man

Tuberculosis: the value of prevention

Tuberculosis (TB) is a bacterial infection (Mycobacterium tuberculosis) that most often affects the lungs. Tuberculosis is transmitted from person to person through respiratory droplets.

Tuberculosis is a preventable and curable disease. But it is also the world’s deadliest infectious disease, killing more than AIDS and malaria combined.

Today, about ¼ of the world’s population has latent tuberculosis infection (LTBI), the stage when TB lies a dormant killer in the body without symptoms. Some persons are at greater risk of developing the disease: treating them successfully is key to changing the course of this epidemic.             

Approx. 10 million
people fell ill with TB in 2018 <sup>11</sup>
1,5 million
people died from TB in 2018 <sup>11</sup>
About ¼
of the world population has latent tuberculosis <sup>11</sup>

What Sanofi does…

Since the 1950s, with the discovery of Rifamycins, still today the cornerstone of tuberculosis treatment, Sanofi has a sustained contribution in fighting tuberculosis and is committed to help reaching the objective to end TB epidemic by 203012.

As a health journey partner, Sanofi is strongly committed to stepping up the fight to eliminate tuberculosis. Including the treatment of latent tuberculosis infection in high risk populations. 

We are developing a new global approach to contribute to eliminating tuberculosis:

Global awareness campaign to expand the treatment coverage of latent tuberculosis infection
New tools to improve educational efforts for healthcare professionals and general public
Bolder partnerships and support to TB prevention and care to countries most in need
Development of innovative and cost-effective therapeutic solutions, to answer unmet needs

Together we can eliminate tuberculosis once and for all!

To learn more about our commitment in tuberculosis…
World tuberculosis day
World TB Day 2020: Sanofi’s commitment on preventing the disease
LTBI
Visit www.ltbi.com to know more about tuberculosis prevention, latent TB infection, risk factors and treatment options
understanding active and latent tuberculosis
Understanding tuberculosis is key for preventing and managing the disease
Understanding high-risk populations for tuberculosis
Learn more about the at-risk population and why treating them successfully is key to changing the course of the epidemic
Man
Factsheet

FIGHTING TUBERCULOSIS

Brochure

TUBERCULOSIS

Sources:

11. WHO fact sheet Tuberculosis - https://www.who.int/news-room/fact-sheets/detail/tuberculosis - Accessed March 24th 2020 
12. United Sustainable Development Goals 3.3 - https://sustainabledevelopment.un.org/sdg3 - Accessed March 24th 2020 

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK